07 August 2014: Clinical Research
Evaluation of Influence of Chronic Kidney Disease and Sodium Disturbances on Clinical Course of Acute and Sub-Acute Stage First-Ever Ischemic Stroke
Anetta Lasek-Bal ABCDEF , Michał Holecki CDEFG , Bartłomiej Kret AB , Anna Hawrot-Kawecka FG , Jan Duława ACDF
DOI: 10.12659/MSM.890627
Med Sci Monit 2014; 20:1389-1394
Abstract
BACKGROUND: Chronic kidney disease (CKD) is an independent risk factor for cardiovascular morbidity and mortality. Hyponatremia is the most common electrolyte disturbance encountered in the neurological and neurosurgical intensive care units, and can exacerbate existing neurological deficits. The objective of this study was to observe the influences of chronic kidney disease and sodium disturbances on the clinical course of acute and sub-acute stages of first-ever ischemic stroke.
MATERIAL AND METHODS: 464 patients with previously diagnosed chronic kidney disease (aged 70.42±11.49 years; 250 women) who had experienced their first-ever ischemic stroke were qualified. The following examinations were performed: serum levels of sodium, creatinine, lipids, estimated glomerular filtration rate (eGFR), neurological state on 1st day of stroke (according to National Institutes of Health Stroke Scale), functional state measured with the Rankin scale, (RS) and mortality rate at 1 month after stroke.
RESULTS: The neurological state on 1st day of stroke was worse and the median RS (30 days after stroke) was higher in patients with eGFR ≤60 ml/ (min×1.73). Men with eGFR ≤60 ml had greater neurological deficits and increased mortality within 1 month. In patients with eGFR >60 ml/, male sex was more often associated with worse outcomes at 1 month after ischemic stroke. Hyponatremia was associated with a more severe state in both the acute and sub-acute stages of stroke, with higher incidence of death within 1 month after stroke. Men with hyponatremia had greater neurological deficits on the 1st day and increased mortality within 1 month.
CONCLUSIONS: Renal impairment and hyponatremia are associated with worse neurological outcomes in patients in the acute stage of their first-ever stroke and within 1 month after the event. Males with impaired kidney function and hyponatremia have a more severe course in their first-ever ischemic stroke, as well as having increased mortality.
Keywords: Aged, 80 and over, Brain Ischemia - complications, Creatinine - blood, Glomerular Filtration Rate, Hyponatremia - complications, Lipids - blood, Poland, Renal Insufficiency, Chronic - complications, Sodium - blood, Stroke - physiopathology
Background
Chronic kidney disease (CKD), the prevalence of which is estimated to be 8–16% worldwide, is an independent risk factor for morbidity and mortality in patients with cardiovascular disease [1]. Sodium is important in maintaining irritability and conduction of nerve and muscle tissues and assists in the regulation of acid-base balance. Hyponatremia is the most common electrolyte disorder encountered in patients in the neurological and neurosurgical Intensive Care Units and can worsen existing neurological deficits [2–4]. Neurological disorders that cause hyponatremia are diverse and include neurotrauma, subarachnoid hemorrhage, intracerebral hemorrhage, meningitis, and stroke [4–6]. One reason for the increased risk of cardiovascular disease in patients with chronic kidney disease is accelerated atherosclerosis. Advanced asymptomatic atherosclerosis in the carotid arteries is observed in patients during the early stages of CKD, with intima and media thickness increasing directly with a decline in glomerular filtration rate [7]. Concentric arterial calcification is associated with arterial stiffness, resulting in a high pulse pressure and increased characteristic aortic impedance. It has been observed that there is an association between intima calcification and increased incidence of ischemic stroke [8].
The aim of this study was to evaluate the influence of chronic kidney disease and sodium disturbances on the clinical course of acute and sub-acute stage of first-ever ischemic stroke.
Material and Methods
LABORATORY TESTS:
Laboratory tests were conducted in the Central Laboratory of the Upper Silesian Medical Centre in Katowice. Venous blood samples (20 ml), taken on admission, were withdrawn into plastic test tubes (Vacutainer system). The tubes were allowed to clot, and then centrifuged at room temperature (1000 × G) for 10 min.
The spectrophotometric method (Point Scientific Inc., Michigan, USA) was used to determine the serum level of sodium (Na), glucose, creatinine, and lipids. Estimated glomerular filtration rate (eGFR) was calculated according to the Chronic Kidney Disease Epidemiology Collaboration [14].
STATISTICAL ANALYSIS:
All parametric values were expressed as mean with standard deviations (SD). All statistical analyses were performed using the STATISTICA 8.0 PL software. The distribution was analyzed using the Kolmogorov-Smirnoff test. Because of the size of the control group, the subgroups, and the nonparametric distribution of some of the parameters, the Mann-Whitney U test was used to compare the study groups and for age we used the
Results
The age of patients with their first-ever stroke and the prevalence of selected comorbidities (hypertension, atrial fibrillation, dyslipidemia and diabetes mellitus) did not differ in subgroups of patients with decreased eGFR (≤60
Neurological condition in the acute stage of a first-ever stroke, evaluated using the NIHSS score, was worse, and the average score in mRS (indicative of a greater degree of disability within 30 days after stroke) was higher in patients with eGFR ≤60 ml/(min×1.73 m2) (Table 2). The mortality rate within 1 month did not differ in patients when divided according to eGFR (7%
The mean serum sodium concentration ranged from 127 to 152 mmol/l. Hyponatremia was associated with a more severe condition of the patients in both the acute and sub-acute stages of stroke and higher incidence of death within 1 month (13.6%
Discussion
CKD is a major risk factor for cardiovascular disease, including stroke [15–17]. Available data indicate an increased risk of cerebral infarction and intracerebral hemorrhage in patients with CKD (40–46% and 39%, respectively) [18–20]. The factors that increase the incidence of stroke in the course of kidney disease include accelerated atherosclerosis, calcification of the cerebral arteries, hemodynamic disturbances, anemia, and anticoagulation therapy [17,20]. Patients with impaired renal function often develop lobar hemorrhages with extensive damage to brain structures, characterized by a more severe clinical course [21]. Chronic kidney failure worsens the early (the course of the acute stage of stroke), as well as the late prognosis (in terms of mobility and survival), and increases the risk of recurrent stroke [22–26]. CKD was 1 of the 9 most important risk factors for recurrent stroke within 1 year of diagnosis of the previous incident, according to the Fukuoka Stroke Registry Study (FSR) [27]. We found that in the acute stage of stroke, patients with a decreased glomerular filtration rate (eGFR <60 ml/min) have a greater degree of neurological damage. These patients often remain dependent on help for daily activities within 1 month after the stroke. The results obtained allow us to conclude that hyponatremia influences the course of the acute and sub-acute stroke periods. The mean age of onset of stroke and the incidence of other diseases likely affect its course, and did not differ significantly for the 2 subgroups. We did not observe that a reduced glomerular filtration rate increased the mortality during the month of follow-up. However, it must be noted that male sex had a negative impact on neurological condition in the acute stage of stroke and survival rate within 1 month of the onset of cerebral ischemia. The age and sex differences in the incidence and course of stroke in men and women have already been demonstrated, but the reason for that phenomenon remains unclear. The impact of sex on the incidence, course, and outcome of stroke is analyzed with respect to the hormonal profile. Risk factor profiles are different, with men having a higher incidence of coronary artery disease, dyslipidemia, diabetes, carotid stenosis, and tobacco smoking, while women had a higher incidence of atrial fibrillation and hypertension. When compared to men, women were older and more significantly impacted by acute stroke. Some authors demonstrated significantly worse functional outcomes for women compared to men at 1 and 5 years after stroke [28–31]. Other authors have observed that hemorrhagic transformation in acute ischemic stroke and increased mortality during hospitalization were more common in patients with CKD [32]. Hirano et al. demonstrated that patients with renal impairment receive less benefit from thrombolytic therapy in the acute stage of stroke [33]. In addition, the same authors demonstrated a higher incidence of iatrogenic bleeding into intracranial structures, causing a high degree of post-stroke morbidity and increased mortality in this group of patients. It has also been demonstrated that chronic kidney disease has a negative effect on the course of other cardiovascular diseases, including coronary heart disease, and a worse prognosis after angioplasty [34–42]. Patients with chronic kidney disease have a higher incidence of occult stroke and microhemorrhages, regardless of incidents of acute cerebral ischemia [16,17]. Imaging studies in patients on hemodialysis (conducted both pre and post mortem) demonstrate the presence of small-vessel infarcts and cerebral atrophy [16,41]. Hyponatremia is another factor that may affect the course and prognosis of patients after stroke. It is the most common electrolyte disorder in hospitalized patients in various clinical settings [42]. Even a small reduction in the serum sodium level is associated with a worse prognosis, regardless of the disease. These observations have also been made in patients with myocardial infarction, pulmonary hypertension, and subarachnoid hemorrhage [43,44]. Additionally, Wannamethee et al. recognized hyponatremia as a potential risk factor for stroke [45]. The relationship between hyponatremia and clinical outcomes after stroke is not completely understood. The worse outcomes in patients with hyponatremia may possibly be explained by osmotic changes (decreased plasma osmolality) resulting in cerebral edema and secondarily increased intracranial pressure. Osmotic changes within neurocytes could also be responsible for cellular damage and their premature death. In the present study, hyponatremia was associated with a more severe condition of the patients in the acute and subacute phases of their first-ever stroke and a higher incidence of mortality within 1 month of the onset of their first-ever stroke. Therefore, hyponatremia observed in patients with their first-ever stroke could be regarded as an essential risk factor for increased mortality and worse prognosis. Interestingly, in the present study, the effect of hyponatremia on both neurologic condition during the first 24 h after stroke and increased mortality rate was significantly higher in men. Other authors obtained similar results. Rodriguez et al. found hyponatremia to be an independent predictor of long-term cumulative mortality rates at 3 and 12 months after stroke and a worse condition at discharge from hospital. It is important to note that no difference has been found when comparing stroke etiologies (ischemic
Conclusions
Renal impairment and hyponatremia are associated with worse neurological condition in patients in the acute stage of their first-ever stroke and worse outcomes within 1 month after a neurological event. Male patients with impaired kidney function and hyponatremia have a more severe course of a first-ever stroke and greater short-term mortality compared to females.
References
1. Levey AS, Sarnak MJ, Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies: J Am Soc Nephrol, 2004; 15; 1307-15, pmid: 15100371
2. Palmer BF, Hyponatremia in patients with central nervous system disease: SIADH versus CSW: Trends Endocrinol Metab, 2003; 14; 182-87, pmid: 12714279
3. Coenraad MJ, Meinders AE, Taal JC, Bolk JH, Hyponatremia in intracranial disorders: Neth J Med, 2001; 58; 123-27, pmid: 11246111
4. Lath R, Hyponatremia in neurological diseases in ICU: Indian J Crit Care Med, 2005; 9; 47-51
5. Cole CD, Gottfried ON, Liu JK, Couldwell WT, Hyponatremia in the neurosurgical patient: Diagnosis and management: Neurosurg Focus, 2004; 16; E9, pmid: 15191338
6. Casulari LA, Costa KN, Albuquerque RC, Differential diagnosis and treatment of hyponatremia following pituitary surgery: J Neurosurg Sci, 2004; 48; 11-18, pmid: 15257260
7. Preston E, Ellis MR, Kulinskaya E, Association between carotid artery intima-media thickness and cardiovascular risk factors in CKD: Am J Kidney Dis, 2005; 46; 856-62, pmid: 16253725
8. London GM, Arterial calcification: cardiovascular function and clinical outcome: Nefrologia, 2011; 31; 644-47, pmid: 22130278
9. , KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: Kidney International Supplements, 2013; 3; 5-14
10. The World Bank, World Development Report 1993: Investing in health, 1993, Oxford, Oxford University Press
11. Mancia G, De Backer G, Dominiczak A, Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC): Eur Heart J, 2007; 28; 1462-536, pmid: 17562668
12. American Diabetes Association, Standards of medical care in diabetes – 2013: Diabetes Care, 2013; 36; 11-66, pmid: 23264287
13. Young FB, Weir CJ, Lees KRGAIN International Trial Steering Committee and Investigators, Comparison of the National Institutes of Health Stroke Scale with disability outcome measures in acute stroke trials: Stroke, 2005; 36; 2187-92, pmid: 16179579
14. Weisscher N, Vermeulen M, Roos YB, What should be defined as good outcome in stroke trials; a modified Rankin score of 0–1 or 0–2?: J Neurol, 2008; 255; 867-74, pmid: 18338195
15. Eikelboom JW, Connolly SJ, Gao P, Stroke risk and efficancy of apixaban in atrial fibrillation patients with moderate chronic kidney disease: J Stroke Cerebrovasc Dis, 2012; 21; 429-35, pmid: 22818021
16. Drew DA, Bhadelia R, Tighiouart H, Anatomic brain disease in hemodialysis patients: a cross-sectional study: Am J Kidney Dis, 2013; 61; 271-78, pmid: 23040011
17. Toyoda K, Cerebrorenal interaction and stroke: Contrib Nephrol, 2013; 179; 1-6, pmid: 23676853
18. Lee SH, Kim BJ, Ryu WS, White matter lesions and poor outcome after intracerebral hemorrhage: a nationwide cohort study: Neurology, 2010; 74; 1502-10, pmid: 20458066
19. Perkovic V, Cass A, Glomerular filtration rate and the risk of stroke: BMJ, 2010; 341; 4390
20. Abramson JL, Jurkovitz CT, Vaccarino V, Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study: Kidney Int, 2003; 64; 610-15, pmid: 12846757
21. Molshatzki N, Orion D, Tsabari R, Chronic kidney disease in patients with acute intracerebral hemorrhage: association with large hematoma volume and poor outcome: Cerebrovasc Dis, 2011; 31; 271-77, pmid: 21178352
22. Kumai Y, Kamouchi M, Hata J, FSR Investigators Proteinuria and clinical outcomes after ischemic stroke: Neurology, 2012; 78; 1909-15, pmid: 22592359
23. Yahalom G, Schwartz R, Schwammenthal Y, Chronic kidney disease and clinical outcome in patients with acute stroke: Stroke, 2009; 40; 1296-303, pmid: 19182072
24. MacWalter RS, Wong SY, Wong KY, Does renal dysfunction predict mortality after acute stroke? A 7-year follow-up study: Stroke, 2002; 33; 1630-35, pmid: 12053003
25. Tsagalis G, Bakirtzi N, Spengos K, Long-term prognosis of combined chronic heart failure and chronic renal dysfunction after acute stroke: Eur J Heart Fail, 2010; 12; 849-54, pmid: 20413394
26. Brzosko S, Szkolka T, Mysliwiec M, Kidney disease is a negative predictor of 30-day survival after acute ischaemic stroke: Nephron Clin Pract, 2009; 112; 79-85
27. Kamouchi M, Kumagai N, Okada Y, Risk score for predicting recurrence in patients with ischemic stroke: the Fukuoka stroke risk score for Japanese: Cerebrovasc Dis, 2012; 34; 351-57, pmid: 23154781
28. Fukuda M, Kanda T, Kamide N, Gender differences in long-term functional outcome after first-ever ischemic stroke: Intern Med, 2009; 48; 967-73, pmid: 19525582
29. Smith DB, Murphy P, Santos P, Gender differences in the Colorado Stroke Registry: Stroke, 2009; 40; 1078-81, pmid: 19211487
30. Duan H, Cai Y, Sun X, Platelet glycoprotein IIb/IIIa polymorphism HPA-3 b/b is associated with increased risk of ischemic stroke in patients under 60 years of age: Med Sci Monit, 2012; 18(1); CR19-24, pmid: 22207115
31. Xu SY, Pan SY, The failure of animal models of neuroprotection in acute ischemic stroke to translate to clinical efficacy: Med Sci Monit Basic Res, 2013; 19; 37-45, pmid: 23353570
32. Sico JJ, Concato J, Wells CK, Anemia is associated with poor outcomes in patients with less severe ischemic stroke: J Stroke Cerebrovasc Dis, 2013; 22; 271-78, pmid: 22100828
33. Hirano T, Thrombolysis and hyperacute reperfusion therapy for stroke in renal patients: Contrib Nephrol, 2013; 179; 110-18, pmid: 23652454
34. Al Suwaidi J, Reddan DN, Williams K, Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes: Circulation, 2002; 106; 974-80, pmid: 12186803
35. Sadeghi HM, Stone GW, Grines CL, Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction: Circulation, 2003; 108; 2769-75, pmid: 14638545
36. Manzano-Fernandez S, Marin F, Pastor-Perez FJ, Impact of chronic kidney disease on major bleeding complications and mortality in patients with indication for oral anticoagulation undergoing coronary stenting: Chest, 2009; 135; 983-90, pmid: 19017872
37. Latif F, Kleiman NS, Cohen DJ, In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry: JACC Cardiovasc Interv, 2009; 2; 37-45, pmid: 19463396
38. Cooper WA, O’Brien SM, Thourani VH, Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database: Circulation, 2006; 113; 1063-70, pmid: 16490821
39. Charytan DM, Yang SS, McGurk S, Rawn J, Long and short-term outcomes following coronary artery bypass grafting in patients with and without chronic kidney disease: Nephrol Dial Transplant, 2010; 25; 3654-63, pmid: 20551089
40. Zakeri R, Freemantle N, Barnett V, Relation between mild renal dysfunction and outcomes after coronary artery bypass grafting: Circulation, 2005; 112; 270-75, pmid: 15998681
41. Steinicke R, Gaertner B, Grittner U, Kidney function and white matter disease in young stroke patients: analysis of the stroke in young Fabry patients study population: Stroke, 2012; 43; 2382-88, pmid: 22723456
42. Anderson RJ, Chung HM, Kluge R, Schrier RW, Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin: Ann Intern Med, 1985; 102; 164-68, pmid: 3966753
43. Goldberg A, Hammerman H, Petcherski S, Hyponatremia and long-term mortality in survivors of acute ST-elevation myocardial infarction: Arch Intern Med, 2006; 166; 781-86, pmid: 16606816
44. Klein L, O’Connor CM, Leimberger JD, Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study: Circulation, 2005; 111; 2454-60, pmid: 15867182
45. Wannamethee G, Whincup PH, Shaper AG, Lever AF, Serum sodium concentration and risk of stroke in middle-aged males: J Hypertens, 1994; 12; 971-79, pmid: 7814858
46. Rodrigues B, Staff I, Fortunato G, McCullough LD, Hyponatremia in the Prognosis of Acute Ischemic Stroke: J Stroke Cerebrovasc Dis, 2013 pii: S1052-3057(13)00277-2
47. Huang WY, Weng WC, Peng TI, Association of hyponatremia in acute stroke stage with three-year mortality in patients with first-ever ischemic stroke: Cerebrovasc Dis, 2012; 34; 55-62, pmid: 22759703
In Press
Clinical Research
Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...Med Sci Monit In Press; DOI: 10.12659/MSM.951027
Clinical Research
Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...Med Sci Monit In Press; DOI: 10.12659/MSM.950516
Review article
Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.951283
Clinical Research
Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 AdultsMed Sci Monit In Press; DOI: 10.12659/MSM.950938
Most Viewed Current Articles
17 Jan 2024 : Review article 10,187,196
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
13 Nov 2021 : Clinical Research 3,708,487
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
14 Dec 2022 : Clinical Research 2,341,643
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 706,524
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387